not tagged
not tagged
['lymsm']
rct of epoch v magrath in high-risk burkitt #17icml
- 89 pts (closed early, planned 250 pts)
- 92% got all codox/ivac cycles
- 2-yr pfs no difference between arms, os 75% both arms
- no cns relapses, more infx aes in codox
valiant effort, not sure if changes practice. #lymsm 
Lymphoma doc & patient-reported outcomes researcher in #lymsm and #mmsm @CUHematology. Founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. 🏳️‍🌈